Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (471-480 of 611) with videos related to

Pageof 62
Sort By:
Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseKathryn G Roberts, Deqing Pei, Dario Campana, et al.
Leukemia|July 3, 2024
Correction: Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.
Human Molecular Genetics|August 1, 2012
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicityGabriele Stocco, Wenjian Yang, Kristine R Crews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Cancer|August 19, 2020
Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemiaSeth E Karol, Todd M Cooper, Paul E Mead, et al.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.
Pageof 62

Showing results (471-480 of 611) with videos related to

Sort By:
Pageof 62
Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseKathryn G Roberts, Deqing Pei, Dario Campana, et al.
Leukemia|July 3, 2024
Correction: Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.
Human Molecular Genetics|August 1, 2012
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicityGabriele Stocco, Wenjian Yang, Kristine R Crews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Cancer|August 19, 2020
Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemiaSeth E Karol, Todd M Cooper, Paul E Mead, et al.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.
Pageof 62